DiGeorge syndrome critical region gene 6 (DGCR6)

DiGeorge syndrome critical region gene 6 (DGCR6) encodes a nuclear phosphoprotein that is highly conserved across vertebrate species. It shares homology with Drosophila gonadal protein and the laminin gamma-1 subunit[2][3][5][6]. DGCR6 is located within the critical 22q11.2 region and is strongly implicated in the etiology of DiGeorge syndrome and related congenital malformations. Functional studies indicate important roles in neural crest cell migration, regulation of heart and pharyngeal arch development, and potentially immune modulation via noncoding RNA species transcribed from the DGCR6 region[4][5]. Altered gene dosage is associated with cardiovascular malformations and neuropsychiatric vulnerability, particularly in the context of deletion syndromes. DGCR6 is not currently considered a pharmacological target, and no drugs directly interact with the gene or its protein product[1][2][3][4][5][6]. If more detail or literature-supported molecular function, clinical utility, or additional biomarker details become available, those should be reviewed as organ-specific biomarker validation is still ongoing[1].

Other names

DGCR6DiGeorge syndrome critical region gene 6DiGeorge syndrome critical region 6DiGeorge syndrome critical region protein 6protein DGCR6

None established. No therapeutic agents with defined mechanism of action through DGCR6